In type 2 diabetic patients, the relationships between 25-hydroxyvitamin D and parathyroid hormone levels, and glycemic control, remain unclear. We evaluated associations between 25-hydroxyvitamin D, parathyroid hormone, and hemoglobin A 1c levels after adjusting for other covariates, including log transformed 25-hydroxyvitamin D levels and log transformed parathyroid hormone levels, in Korean patients with type 2 diabetes. In total, 1,175 patients with type 2 diabetes were selected from 8,857 individuals who completed the baseline survey of the Dong-gu study, conducted in Korea from 2007 to 2010. After adjusting for other covariates, we found that the mean hemoglobin A 1c level was inversely associated with the 25-hydroxyvitamin D level (Q1: 7.47% [7.30-7.63], Q2: 7.25% [7.09-7.40], Q3: 7.17% [7.02-7.32], Q4: 7.19% [7.02-7.35]; p for trend = 0.021, p for between groups = 0.050) and the parathyroid hormone level (Q1: 7.35% [7.19-7.51], Q2: 7.34% [7.19-7.50], Q3: 7.28% [7.13-7.43], Q4: 7.09% [6.94-7.24]; p for trend = 0.022, p for between groups = 0.048). However, the mean fasting glucose level was not associated with either the 25-hydroxyvitamin D or parathyroid hormone level. In conclusion, inverse associations were evident PLOS ONE |
Introduction
Diabetes and associated complications are becoming major public health problems. Diabetes affected 422 million subjects in 2014 and total deaths caused by high blood glucose levels in 2012 numbered 3.7 million [1] . Thus, improvement of glycemic control is an increasingly important clinical issue.
Some 80-90% of vitamin D is produced from skin 7-dehydrocholesterol upon adequate exposure to ultraviolet light; only 10-20% is derived from dietary sources such as oily fish, milk, butter, eggs, and various supplements [2] . Vitamin D is first hydroxylated in the liver to 25-hydroxyvitamin D (25[OH]D), which is the major circulating form; it is then further hydroxylated in the kidney, to 1,25-dihydroxyvitamin D (1, 25 [OH] 2 D), which is the biologically active form [3] . 1,25(OH) 2 D is known to regulate glucose metabolism by interacting with the 1-alpha-hydroxylase enzyme and the vitamin D receptor (VDR) in pancreatic β-cells [4, 5] . Vitamin D plays an important role in bone and mineral metabolism, and a deficiency thereof is associated with the development of metabolic bone diseases including rickets and osteomalacia [6] . Recently, several health problems have been associated with absence of the non-skeletal actions of vitamin D [7, 8] .
However, no consensus on any association between vitamin D level and glycemic control has been attained in either observational studies or clinical trials featuring vitamin D supplementation [9] . Several authors have reported inverse associations between the 25(OH)D level and the effectiveness of glycemic control [10, 11] ; others found no such associations [12] . Moreover, the effect of parathyroid hormone (PTH), a known mediator of vitamin D action, was not considered.
Most previous studies sought to explain the relationship between vitamin D and PTH in the context of hypovitaminosis D and secondary hyperparathyroidism; thus, data on the independent effects of vitamin D and PTH on the HbA 1c levels of general populations that do not exhibit hypovitaminosis D are lacking. Koreans are of particular interest because the overall prevalence of vitamin D deficiency in Korea is 1.3-to-1.5-fold greater than in the USA, and the burden of diabetes is increasing in Korea [13] . Therefore, we sought independent associations between 25(OH)D, PTH, and HbA 1c levels in Korean patients with type 2 diabetes.
Materials and Methods

Subjects
The Dong-gu study is an ongoing prospective population-based study investigating the prevalence and incidence of, and risk factors for, chronic disease in an elderly urban population. The Dong-gu study complies with all tenets of the Declaration of Helsinki and was approved by the Institutional Review Board of Chonnam National University Hospital. All participants gave written informed consent. Detailed information on the study participants and the measurements performed in relation to this population have been previously published [14] . National resident registration records were used to identify potential study participants. From 2007 to 2010, 34 ,040 eligible subjects aged 50 years who resided in the Dong-gu district of Gwangju Metropolitan City in South Korea (35°N) were invited by telephone to participate in the study, and 9,260 subjects were subsequently enrolled (response rate: 27.2%; 3,713 males and 5,547 females). We selected 1,246 participants who were taking medication to treat type 2 diabetes. After excluding 71 participants because their data were incomplete; no vitamin D data (n = 58) or no HbA 1c data (n = 13), we included 1,175 subjects (563 males and 612 females) in the final analyses.
Study measurements
Trained examiners interviewed all participants using a standardized questionnaire to assess smoking status, the use of anti-hypertensive medications, and the duration of diabetes. Height was measured to the nearest 0.1 cm and weight to the nearest 0.1 kg. The body mass index (BMI) was calculated by dividing a subject's weight (in kg) by the height squared (in m 2 ).
Blood samples were drawn from antecubital veins following 12-h overnight fasts; the sera were separated within 30 min, and samples were stored at -70°C prior to analysis. The levels of fasting blood glucose, total cholesterol, triglycerides, and high-density lipoprotein (HDL) cholesterol were measured using enzymatic methods on an automatic analyzer (Hitachi-7600; Hitachi, Ltd., Tokyo, Japan). Low-density lipoprotein (LDL) cholesterol was measured as described by Friedewald et al. [15] , except when the triglyceride level exceeded 400 mg/dL. HbA 1c levels were analyzed by high-performance liquid chromatography using the VARIANT II system (Bio-Rad, Hercules, CA, USA). Measurement of 25(OH)D and PTH levels. Serum 25(OH)D and PTH levels were measured with the aid of a microparticle immunoassay system detecting chemiluminescence (Architext i2000; Abbott Diagnostics, Abbott Park, IL, USA). In a comparative study of automated immunoassays and liquid chromatography-tandem mass spectrometry methods (LC-MS/MS) [16] , the Abbott 25(OH)D assay was comparable to LC-MS/MS; the concordance correlation coefficient was 0.85, and the mean bias was 4.56 ng/mL. The coefficient of variation for the total analytic precision of this assay was < 10% for 25(OH)D. According to the manufacturer's specifications, the assay has 105% cross-reactivity with 25(OH)D3, 82% cross-reactivity with 25(OH)D2, 12.6% cross-reactivity with 1,25(OH) 2 D3, 112% cross-reactivity with 24,25(OH) 2 D3, and minimal cross-reactivity with 3-epimer of 25(OH)D3 (2.7%).
Statistical analysis
Data are presented as means ± standard deviations (SDs) or as percentages by the 25(OH)D and PTH quartiles because no consensus about cut-off value for 25(OH)D and PTH has been achieved [17, 18, 19] ; >19.0 ng/mL, PTH quartiles: Q1; <26.2 pg/mL, Q2; 26.2-34.8 pg/mL, Q3; 34.9-46.1 pg/mL, and Q4; >46.1 pg/mL). Analysis of covariance (ANCOVA) (three models) was used to compare the mean HbA 1c and fasting glucose levels by the 25(OH)D and PTH quartiles. Model 1 was adjusted for the month of blood collection, sex, and age. Model 2 included the variables of Model 1 and smoking status, the use of anti-hypertensive medication, the duration of diabetes, and total cholesterol, triglyceride, and HDL cholesterol levels. Model 3 included the variables of Model 2 and the log-PTH and log-25(OH)D data. All statistical analyses were performed using SPSS software version 15.0 (SPSS, Inc., Chicago, IL, USA). A p-value <0.05 was considered to reflect statistical significance.
Results
Characteristics of subjects according to 25(OH)D quartiles
The characteristics of the 1,175 subjects (563 males and 612 females) included in the present study are listed in Table 1 . A higher 25(OH)D level tended to be associated with male gender, a greater height, a heavier weight, smoking status, a greater level of physical activity, and lower levels of total cholesterol, triglycerides, LDL cholesterol, HDL cholesterol, HbA 1c , and PTH. 25 (OH)D levels showed a seasonal pattern being higher in June and July than in April and May.
Characteristics of subjects according to PTH quartiles
Subject characteristics by PTH quartile are listed in Table 2 Table 3 . After adjusting for the month of blood collection, sex, age, BMI, smoking status, the extent Consistent with earlier reports, we found that the 25(OH)D level was influenced by month of blood collection [20] , physical activity [21] , lipid profiles [22, 23] and PTH [24, 25] . Unlike the findings of previous studies [20, 26] , BMI was not associated with the 25(OH)D level. The Longitudinal Aging Study conducted in Amsterdam [27] sought associations between 25(OH) D levels and bodily composition variables, including BMI, waist-to-hip ratio, waist circumference, total body fat, and total body fat percentage. The association of the 25(OH)D level with the total body fat percentage was stronger than were the associations with other bodily composition variables. This indicates that adiposity, and not simply body weight or BMI per se, is associated with the 25(OH)D concentration [27] . When we analyzed association between the 25(OH)D levels with body fat percentage in our data (data are not shown), body fat percentage is inversely associated with 25(OH)D quartiles (Q1: 34.6±7.2%, Q2: 33.6±7.3%, Q3: 31.0±7.7%, Q4: 29.2±6.3%, p<0.001) like previous study [27] .
Many studies have explored associations between 25(OH)D levels and the prevalence of diabetes; lower 25(OH)D levels were associated with a higher prevalence of type 2 diabetes [10, 28, 29] . However, any relationship between the 25(OH)D level and the HbA 1c level remains unclear. Some authors reported positive relationships between the 25(OH)D level and the HbA 1c level [30] ; others presented no association [12] ; the others reported inverse associations [10, 11, 31] .
We found that the association between the HbA 1c and 25(OH)D levels was significant, but no association was apparent between the fasting glucose and 25(OH)D levels. In a previous study with 668 older subjects [10] , an association was evident between 25(OH)D and HbA 1c levels, but not between 25(OH)D and fasting glucose levels (as also found by us). The 25(OH) D level is related to the HbA 1c level but not to the fasting glucose level, because the HbA 1c level is a long-term marker of glycemic control, reflecting changes that take place over about 2-3 months [32] . Such changes are difficult to capture using single measurements of fasting glucose levels.
We found that, after adjustment for the log-PTH level, the association between the HbA 1c and 25(OH)D levels remained significant. To the best of our knowledge, only a few previous [33] , associations of the 25(OH)D level with fasting glucose and insulin levels were independent of the serum PTH concentration. In another study using NHANES data collected from 2003-2006 [11] , an analysis of 9,773 subjects showed that the 25(OH)D level was inversely associated with the HbA 1c level after adjusting for other covariates including the PTH level, which is similar to what we found. 1,25 dihydroxyvitamin D3 (1, 25 [OH] 2 D3) regulates insulin synthesis/secretion by controlling calcium homeostasis via a mechanism involving PTH [34, 35] , and it may also (in a PTH-independent manner) influence glucose metabolism via activation of VDRs on pancreatic β-cells [36] and protects β-cells from immune attack [37] . Recently, it has been shown that vitamin D3 can be transformed by the steroidogenic enzyme cytochrome P450scc (CYP11A) into not only 25(OH)D3 and 1,25(OH) 2 D3, but also the novel metabolites 20(OH)D3, 22(OH)D3, 20,22(OH) 2 D3, and 20,23(OH) 2 D3 [38, 39] . The major product of CYP11A acting on vitamin D3, 20(OH)D3 is noncalcemic [40] , and it may regulate 1,25(OH) 2 D3 production in a PTH-independent manner [41] .
We found that the HbA 1c level was inversely associated with the PTH level, independently of 25(OH)D status. This is surprising; previous studies associated elevated PTH levels with glucose intolerance and insulin insensitivity [42, 43] . This discrepancy may not be attributable to differences in PTH distribution. The mean (with standard deviation [SD]) level of PTH in one study was 42.1±15.7 pg/mL [43] , and the mean (with standard error [SE]) level in another study was 40.11(1.74) pg/mL [42] , whereas the mean ± SD and mean (SE) levels in our study were 39.5±24.7 pg/mL and 39.5 (0.72) pg/mL, respectively. The precise mechanisms how increased PTH is associated with decreased HbA 1c level are not clear. Under normal physiological conditions, low levels of vitamin D should stimulate PTH secretion, and low levels of PTH should increase calcium uptake from both the gut and skeleton [44] . Therefore, high-level PTH reflects a low calcium level, which may improve glucose-tolerance [45] , and ameliorate both insulin sensitivity and insulin secretion [46] .
The primary strengths of this study lie in its population based design and use of a relatively large sample size, which minimized selection bias and provided sufficient statistical power. However, a number of limitations should also be considered. First, the present study employed a cross-sectional design. Second, it was comparatively limited in its ability to explain seasonal changes in 25(OH)D, partly due to a lack of information regarding sun exposure during seasonal cycles. Finally, only a single serum 25(OH) D measurement was taken, and the data therefore reflect only a single point in time rather than long-term exposure.
Conclusion
Inverse associations were evident between HbA 1c, 25(OH)D and PTH levels in Korean patients with type 2 diabetes. Such associations remained significant after adjustment for covariates, including the log-25(OH)D and log-PTH values.
